Trials / Active Not Recruiting
Active Not RecruitingNCT03045029
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- United Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This prospective, observational, multicenter, patient registry will follow patients who are receiving treatment with Orenitram for the treatment of PAH for up to 78 weeks from Orenitram initiation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oral treprostinil | Sustained-release oral tablets for TID administration |
Timeline
- Start date
- 2017-07-18
- Primary completion
- 2027-03-01
- Completion
- 2027-03-01
- First posted
- 2017-02-07
- Last updated
- 2026-04-02
Locations
41 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03045029. Inclusion in this directory is not an endorsement.